() is important for the industry because they can use this data to submit future amendments to the approved indications for their products and demonstrate the safety and effectiveness of their products, especially compared to others. ()is especially an important tool for regulatory agencies and the physicians/patients using the products. When a regulator grants authorization for a drug, it is largely a result of the data obtained from ()

Postmarket research, randomized clinical trials (RCTs).

Click To Flip the Card

Comments:

Public health midterms

navigate_before navigate_next